Autolomous

It was a pleasure to attend the Royal Society of Medicine's Artificial Intelligence in Science and Medicine Ellison-Cliffe lecture, delivered by Professor Christopher Bishop, Technical Fellow and Director of Microsoft Research AI for Science. The discussion included real-world examples of AI’s applications ranging from drug discovery to material design. Professor Bishop highlighted the significant impact of AI on medical diagnosis, treatment, and drug development. He provided an insightful overview of the diverse applications of machine learning including, deep learning, generative AI and transfer learning. We were captivated by the potential of AI-powered diagnostics and predictive modelling to revolutionise the study of biologics. A particular highlight was the introduction of Gigapath, Microsoft’s cutting-edge foundation model for digital pathology, enabling more precise and efficient analysis of tissue samples. The lecture underscored the importance of cross-disciplinary collaboration in AI, explaining how AI researchers and domain experts, working together, could unlock AI’s full potential, leading to groundbreaking advancements in science and medicine. We look forward to seeing how AI continues to revolutionise these fields, and more specifically, cell and gene therapy manufacturing. #AI #MachineLearning #Healthcareinnovation Achraf Chairi Chris Obasi Maxfield Lanzi

Mark your calendars for 21 November and join us for our next Link Up Drinks event, this time hosted by Hästens Beds at their beautiful Marylebone showroom! 🛏   Not only will you get a taste of what makes a good night’s sleep truly extraordinary, but you’ll also have the chance to meet the newest members of SCC UK, Autolomous, DSV - Global Transport and Logistics, Moyagi, MoneyWise, and Jensten. Don’t miss out on an evening filled with relaxed conversation, connections, and a glimpse into the craftsmanship behind Hästens’ world-class beds. Register your interest today: https://lnkd.in/dJtVQV_a   #SCCLinkUpDrinks #Network #SwedishBritish #Event #SwedenUK #London #SCCUK

Really interesting Q&A article on how #AI #artificialintelligence is affecting #clinicaltrials, with Dr. Cheryl Barton speaking one on one to Alexander Seyf, CEO, Autolomous. It covers how AI will radically change #clinicaltrials, what AI can contribute towards #trialdesign, how AI is only as good as the available data, and how AI #regulatory frameworks will be critical to regulate input. Would love to hear comments about Alexander's thoughts here. https://lnkd.in/dHT5q_D6

We were delighted to attend Innovation Forum’s Healthcare 2.0 Conference exploring the latest advancements in CGT. We had the pleasure of hearing from Prof. Manohar Bance on the impact of cell and gene therapies and his pioneering work for hearing loss. The distinguished panel of experts, including John Stone, Prof. costanza emanueli, Prof. Simon Waddington and Jesus Zurdo highlighted the ongoing advancements in the CGT field and explored solutions to address the challenges posed by high therapy costs, such as improved healthcare collaboration, automation, and digitalization. The business panel discussion featuring Jack O'Meara, Kathryn Golden, Lee Dunham and Michael Anstey sparked lively discussions. The panel explored the challenges of high manufacturing costs and stressed the importance of early automation in mitigating risks. They also emphasised the need for a well-planned manufacturing strategy to streamline the transition to GMP. Autolomous is proud to be part of the CGT automation and digitalization space. Together, we can make life-saving therapies a reality for more patients. #cellandgenetherapy #celltherapy #genetherapy #digitalization #healthcareinnovation

A massive thank you to the Alliance for Regenerative Medicine for hosting the 2024 Cell & Gene Meeting on the Mesa. It was a valuable opportunity to connect with industry experts and discuss the latest advancements in the cell and gene therapy sector. We are thrilled to see everyone's openness to collaboration and commitment to making cell and gene therapy more accessible. Together, we can make life-saving therapies a reality for more people. Let's keep the momentum going and continue to push the boundaries of this groundbreaking field. #CellandGeneTherapy #CellTherapy #GeneTherapy #CGMesa24 Alexander Seyf Lynn Fischer Alexis Blain Walid Fahme Alexa Crăciunescu

Great to see Jonathan D. Grinstein, PhD's article on #MeetingontheMesa published in Inside Precision Medicine, sister publication to Genetic Engineering & Biotechnology News. Really useful focus, comment and input from Alexander Seyf, CEO, Autolomous, discussing the need for digitialization in #CGT. Fascinating that from a journalist that has full access to a leading conference in the #cellandgenetherapy sector, the lead issue to report on from his highly experienced point of view is the digitalization of deliver of these #therapies, and not the #development of the therapy itself. That to me demonstrates how far this sector has moved on in the 15+ years I've been involved with it. https://lnkd.in/eB9cicxR

Last week, our team attended the The CGT Circle London event. It was an inspiring opportunity to connect with brilliant women leaders in the cell and gene therapy field. The insightful panel discussion featuring Prof Eli Keshavarz-Moore, Prof Suzanne Farid and Prof Martina Micheletti highlighted the critical role of empowering women, fostering collaboration to drive innovation and prioritising personal goals. We're committed to supporting initiatives that promote diversity, equity, and inclusion in the cell and gene therapy space. We look forward to continuing our involvement in events like these and working towards a more equitable future for all. #cellandgenetherapy #womeninSTEM #collaboration #healthcareinnovation Isabelle Blewden Mirthe van Wijk Joanna K. Kristine Davies

Last week, we had the privilege of attending Impact 2024, a sustainability focused event, hosted by the Swedish Chamber of Commerce for the UK. This event brought together professionals from diverse industries to share insights and discuss solutions to pressing environmental challenges. Highlights included thought-provoking discussions with experts like Romina Pourmokhtari, the Swedish Minister for Climate and the Environment, as well as Clover Hogan, the founder and advisor of Force of Nature. Their insights reinforced the urgency of addressing climate change and the importance of collective action. The event left us empowered to make a positive impact on the planet through our own actions individually, as well as with Autolomous. #SCC #SCCImpact #GreenTransition #Network #SwedishBritish #SwedenUK #London #Sustainability James Rutley Alexa Crăciunescu Mirthe van Wijk

Join us today at the Alliance for Regenerative Medicine’s 2024 Cell & Gene Meeting on the Mesa to hear our CEO Alexander Seyf present how our platform, autoloMATE® streamlines cell and gene therapy manufacturing processes, reduces costs, and accelerates the delivery of these innovative treatments. 🕘 Time: Oct 9, 11:45 AM - 12 PM 👉 Location: FLW Ballroom F We look forward to seeing you there! #CellandGeneTherapy #CellTherapy #GeneTherapy #CGMesa24

The theme from D1 Cell and Gene Meeting on the Mesa (Alliance for Regenerative Medicine) was about coming down to earth & atomizing the commercialization and industrialization problems of cell and gene therapy into attainable building blocks. Check out my convos w/ Dyno Therapeutics, Profluent, Astellas Gene Therapies / Astellas Pharma, Autolomous. Stay cool!